Laser treatment of cutaneous angiokeratomas: A systematic review. Issue 6 (19th November 2017)

• Record Type: Journal Article
• Authors: Nguyen, Jannett; Chapman, Lance W.; Korta, Dorota Z.; Zachary, Christopher B.
• Is Part Of: Dermatologic therapy. Volume 30:Issue 6(2017)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-11-19
• Subjects: angiokeratoma -- laser -- vascular; Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/dth.12558
• Languages: English
• ISSNs: 1396-0296

Abstract

Abstract: Angiokeratomas can present therapeutic challenges, especially in cases of extensive lesions, where traditional surgical methods carry high risks of scarring and hemorrhage. Argon, pulsed dye (PDL), neodymium‐doped yttrium aluminum garnet (Nd:YAG), copper vapor, potassium titanyl phosphate, carbon dioxide, and erbium‐doped yttrium aluminum garnet (Er:YAG) lasers have emerged as alternative options. To review the use and efficacy of lasers in treating angiokeratomas. A PubMed search identified randomized clinical trials, cohort studies, case series, and case reports involving laser treatment of cutaneous angiokeratomas. Twenty‐five studies were included. Quality ratings were assigned using the Oxford Centre for Evidence‐Based Medicine scheme. Several laser modalities are effective in treating multiple variants of angiokeratomas. Vascular lasers like PDL, Nd:YAG, and argon are the most studied and of these, PDL offers the safest side effect profile. Nd:YAG may be more effective for hyperkeratotic angiokeratomas. Combination treatment with multiple laser modalities has also demonstrated some success. Lasers are a promising treatment option for angiokeratomas, but current use is limited by the lack of treatment guidelines. There are limited high quality studies comparing laser treatments to each other and to non‐laser options. Additional studies are needed to establish guidelines and to optimize laser parameters.